BMO On Abbott Labs: 'It's Likely Time For The Stock To Take A Pause'

By: via Benzinga
BMO downgrades Abbott Laboratories (NYSE: ABT) to Market Perform from Outperform as shares are trading near the brokerage’s $48 ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.